Johnson & Johnson (JNJ) EBT Margin (2009 - 2026)

Johnson & Johnson has disclosed EBT Margin across 18 years of filings, most recently posting 24.89% for Q1 2026.

• EBT Margin for Q1 2026 came in at 24.89%, down 3737.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 25.88% (down 390.0% YoY), and the FY2025 annual result was 34.59%, up 1580.0% from the prior year.
• EBT Margin came in at 24.89% for Q1 2026 at Johnson & Johnson, up from 20.22% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 62.26% in Q1 2025 to a low of 6.16% in Q2 2023.
• The 5-year median for EBT Margin is 24.89% (2026), against an average of 24.0%.
• Across the five-year window, EBT Margin soared 4489 bps in 2025 and slumped 3737 bps in 2026, its largest moves.
• Johnson & Johnson's EBT Margin stood at 25.87% in 2022, then declined by 13 bps to 22.56% in 2023, then slipped by 23 bps to 17.26% in 2024, then rose by 17 bps to 20.22% in 2025, then climbed by 23 bps to 24.89% in 2026.
• The last three EBT Margin figures came in at 24.89% (Q1 2026), 20.22% (Q4 2025), and 31.23% (Q3 2025), per Business Quant data.